RT Journal Article
SR Electronic
T1 Early Diagnosis and Clinical Significance of Acute Cardiac Injury - Under the Iceberg: A Retrospective Cohort Study of 619 Non-critically Ill Hospitalized COVID-19 Pneumonia Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.06.20147256
DO 10.1101/2020.07.06.20147256
A1 Xie, Yang
A1 Chen, Sichun
A1 Wang, Xueli
A1 Li, Baige
A1 Zhang, Tianlu
A1 He, Xingwei
A1 Sun, Ningling
A1 Wang, Luyan
A1 Zeng, Hesong
A1 Shen, Yin
YR 2020
UL http://medrxiv.org/content/early/2020/07/07/2020.07.06.20147256.abstract
AB Rationale Coronavirus disease 2019 (COVID-19) can cause a viral pneumonia together with other extrapulmonary complications. Acute cardiac related injury (ACRI) is common in hospitalized COVID-19 patients.Objective To explain the pathological mechanism of ACRI and improve the treatment strategy by retrospectively observing the factors associated with ACRI and factors affecting the prognosis of ACRI with COVID-19 at an early stage.Methods 619 COVID-19 patients were from Tongji Hospital, Wuhan. Student’s t test was used for continuous variables while Pearson χ2 test for categorical factors. Univariable and multivariable logistic regression models were applied to estimate odds ratio (OR) with 95% confidence interval (CI).Results Among the 619 OOS Level-I hospitalized COVID-19 patients, 102 (16.5%) were defined as ACRI (stage-1: 59 cases, stage-2: 43 cases). 50% of ACRI patients developed into severe cases and 25 patients died(CFR=24.5%), 42 times that of non-ACRI patients. Elderly (OR=2.83, P<0.001), HTN (OR=2.09, P=0.005), γ-globulin (OR=2.08, P=0.004), TCM (OR=0.55, P=0.017), PLT (OR=2.94, P<0.001) and NLR (OR=2.20, P=0.004) were independently correlated with ACRI. SBP ⩾ 140, dyspnea, DM, smoking history were correlated with ACRI-stage2 only. In the prognostic subgroup analysis of ACRI patients, γ-globulin treatment could prolong LOS (29.0 ± 7.2 days Vs 23.5 ± 8.1 days, P=0.004). TCM (OR=0.26, P=0.006), SBP ⩾ 160 (OR= 22.70, P=0.005), male (OR=2.66, P=0.044) were associated with severe illness while corticosteroids treatment (OR=3.34, P=0.033) and male (OR=4.303, P=0.008) with death. Surprisingly, we found the mortality of non-elderly patients is higher than elderly (32.4% VS 20.0%, P=0.164), and both IKF and RASI treatment were not correlated with any prognostic indicators including severe, death and LOS.Conclusion This study observed that several non-traditional issues were associated with early cardiac injury in COVID-19 while many traditional cardiovascular risk factors were not. Besides elderly and male, hypertension was confirmed to be the most important risk factor.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by COVID-19 Emergency Response Project of Wuhan Science and Technology Department (2020020201010018).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Tongji Hospital, Wuhan, China, approved this retrospective study and written informed consent was waived (No. TJ-C20200140).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw data was extracted from electronic medical records with standardized data collection forms in Tongji Hospital (Wuhan, China), which had been approved by the Research Ethics Commission of Tongji Hospital, Tongji medical college of HUST. The data used to support the findings of this study are available from the corresponding author upon request.ACIAcute cardiac injuryACRIAcute cardiac related injuryAMIAcute myocardial injuryCFRCase-fatality rateCHDCoronary heart diseaseCOVID-19Coronavirus disease-2019CRPC-reactive proteincTnICardiac troponin ICVDCardiovascular diseaseDDD-DimerDMDiabetes mellituseGFREstimated glomerular filtration rateHSBPHigh systolic blood pressureIKFImpaired kidney functionIL-6Interleukin 6IVIGIntravenous immunoglobulinLDHLactate dehydrogenaseLOSLength of stayMAPMean arterial pressureNEUNeutrophilNT-proBNPN-terminal pro-brain natriuretic peptideNLRNeutrophil lymphocyte ratioOOSOximeter oxygen saturationRASRenin-angiotensin-aldosterone systemRASIRenin-angiotensin-aldosterone system inhibitorsScrSerum creatinineWHOWorld Health Organization